Esperion Therapeutics ESPR Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's common stock shares issued?
- Esperion Therapeutics (ESPR) reported common stock shares issued of 259.4M in Q1 2026.
- How has Esperion Therapeutics's common stock shares issued changed year-over-year?
- Esperion Therapeutics's common stock shares issued increased by 30.6% year-over-year, from 198.7M to 259.4M.
- What is the long-term trend for Esperion Therapeutics's common stock shares issued?
- Over 5 years (2020 to 2025), Esperion Therapeutics's common stock shares issued has grown at a 54.7% compound annual growth rate (CAGR), from 27.9M to 247.2M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.